RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R0012043 | PF-07202954 | PF-07202954 is a weakly basic DGAT2 inhibitor with an IC50 of 10 nM for human DG |
| R0012044 | AZD1656 | AZD1656 is a potent, selective and orally active glucokinase activator with an E |
| R0012045 | 反式-4-[4-(4-氨基-7,7-二甲基-7H-嘧啶并[4,5-B][1,4]噁唑-6-基)苯基]-环己基乙酰胺 | T863 is an orally active, selective and potent DGAT1 (acyl-CoA:diacylglycerol ac |
| R0012046 | 反式-4-[4-(4-氨基-7,8-二氢-5-氧代嘧啶并[5,4-f][1,4]氧氮杂卓-6(5H)-基)苯基]环己烷乙酸 | PF-04620110 is a potent, selective and orally bioavailable diglyceride acyltrans |
| R0012047 | Pradigastat(LCQ-908) | Pradigastat (LCQ-908) is a potent, selective and orally active diacylglycerol ac |
| R0012049 | (R)-CR8(CR8, (R)-Isomer) | (R)-CR8 (CR8), a second-generation analog of Roscovitine, is a potent CDK1/2/5 |
| R0012050 | N5-(6-氨基己基)-N7-苄基-3-异丙基吡唑并[1,5-a]嘧啶-5,7-二胺 | BS-181 is a potent and selective CDK7 inhibitor (IC50=21 nM) than Seliciclib (HY |
| R0012051 | CT7001盐酸盐 | Samuraciclib hydrochloride (CT7001 hydrochloride) is a potent, selective, ATP-co |
| R0012053 | TVB-3166 | TVB-3166 is an orally-available, reversible, and selective fatty acid synthase ( |
| R0012054 | Denifanstat(TVB-2640) | Denifanstat (TVB-2640) is an orally active and potent Fatty Acid Synthase (FASN) |
| R0012055 | diABZI STING agonist-1 | diABZI STING agonist-1 is a selective stimulator of interferon genes (STING) rec |
| R0012056 | STING agonist-3 | STING agonist-3, extracted from patent WO2017175147A1 (example 10), is a selecti |
| R0012057 | CC-885 | CC-885 is a cereblon (CRBN) modulator with potent anti-tumour activity. CC-885 i |
| R0012058 | NVP-DKY709 | NVP-DKY709 is a potent IKZF2 inhibitor for the research of cancers. |
| R0012059 | Migoprotafib(GDC-1971) | Migoprotafib (GDC-1971) (compound 199) is a SHP2 inhibitor. |
| R0012060 | G150 | G150 is a highly selective human cyclic GMP-AMP synthase (h-cGAS) inhibitor with |
| R0012061 | LSN3318839 | LSN3318839 is an orally efficacious positive allosteric modulator of the glucago |
| R0012062 | (S,R)-LSN3318839 | (S,R)-LSN3318839 is the stereoisomer of LSN3318839 (HY-142162). LSN3318839 is an |
| R0012063 | GLP-1受体激动剂1 | Orforglipron (LY3502970) (Compound 67) is an orally active agonist for Glucagon- |
| R0012064 | AZD0780(PCSK9-IN-12) | PCSK9-IN-12 is a heteroaryl compound. PCSK9-IN-12 has bind affinity for PCSK9 wi |
| R0012065 | Tri-GalNAc(OAc)3 TFA | Tri-GalNAc(OAc)3 TFA is a tri-GalNAc ligand that can be used for the synthesis o |
| R0012066 | 1426159-34-3 | |
| R0012067 | (3R,5S)-5-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)吡咯烷-3-醇 | |
| R0012068 | Bexotegrast (PLN-74809) | Bexotegrast (PLN-74809) is an orally active, potent dual αvβ6/αvβ1 integrin inhi |
| R0016001 | DPO-1 | DPO-1 is a potent inhibitor of the voltage-gated potassium channel subtype Kv1.5 |
